Het vaststellen van botmetastases in hormoon naïeve prostaatkanker in PET/CT met behulp van [18F]FDHT
- Conditions
- hormone naive prostate cancer metastasized to bone, hormoon naïve bot-gemetastaseerde prostaatkanker
Recruitment & Eligibility
- Status
- Other
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
•metastasized prostate cancer, ≥2 lesions in bone, confirmed by
ovisible lesions on bone scan, CT and/or MRI consistent with disease
Exclusion Criteria
•active cancer besides prostate cancer
•age < 50 years
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patients with metastasized prostate cancer will undergo a [18F]FDHT PET/CT before start of ADT. A second scan will be performed three months after start of ADT.<br>Primary outcome is the amount of decreased uptake of 18F-FDHT per lesions before and after three months of ADT.
- Secondary Outcome Measures
Name Time Method